Therapeutic modulation of gut microbiota in inflammatory bowel disease: More questions to be answered
- PMID: 27743467
- DOI: 10.1111/1751-2980.12422
Therapeutic modulation of gut microbiota in inflammatory bowel disease: More questions to be answered
Abstract
Patients with inflammatory bowel disease (IBD) exhibit impaired control of the microbiome in the gut, and 'dysbiosis' is commonly observed. Western diet is a risk factor for the development of IBD, but it may have different effects on gut microbiota between IBD and non-IBD individuals. Exclusive enteral nutrition (EEN) can induce remission in pediatric Crohn's disease with a decrease in gut microbial diversity. Although there are some theoretical benefits, actual treatment effects of prebiotics and probiotics in IBD vary. High-quality studies have shown that VSL#3 (a high-potency probiotic medical food containing eight different strains) exhibits benefits in treating ulcerative colitis, and gut microbial diversity is reduced after treated with VSL#3 in animal models. The effect of fecal microbiome transplantation on IBD is controversial. Increasing microbial diversity compared with impaired handling of bacteria presents a dilemma. Antibiotics are the strongest factors in the reduction of microbiome ecological diversity. Some antibiotics may help to induce remission of the disease. Microbiome alteration has been suggested to be an intrinsic property of IBD and a potential predictor in diagnosis and prognosis. However, the effects of therapeutic modulations are variable; thus, more questions remain to be answered.
Keywords: fecal microbiome transplantation; gastrointestinal microbiome; inflammatory bowel diseases; prebiotics; probiotics; therapeutics.
© 2016 Chinese Medical Association Shanghai Branch, Chinese Society of Gastroenterology, Renji Hospital Affiliated to Shanghai Jiaotong University School of Medicine and John Wiley & Sons Australia, Ltd.
Similar articles
-
Microbiota in Inflammatory Bowel Disease Pathogenesis and Therapy: Is It All About Diet?Nutr Clin Pract. 2015 Dec;30(6):760-79. doi: 10.1177/0884533615606898. Epub 2015 Oct 9. Nutr Clin Pract. 2015. PMID: 26452390 Review.
-
Gut microbiota and inflammatory bowel disease: so far so gut!Minerva Gastroenterol Dietol. 2017 Dec;63(4):373-384. doi: 10.23736/S1121-421X.17.02386-8. Epub 2017 Mar 14. Minerva Gastroenterol Dietol. 2017. PMID: 28293937 Review.
-
Current understanding of microbiota- and dietary-therapies for treating inflammatory bowel disease.J Microbiol. 2018 Mar;56(3):189-198. doi: 10.1007/s12275-018-8049-8. Epub 2018 Feb 28. J Microbiol. 2018. PMID: 29492876 Review.
-
Therapeutic Advances in Gut Microbiome Modulation in Patients with Inflammatory Bowel Disease from Pediatrics to Adulthood.Int J Mol Sci. 2021 Nov 19;22(22):12506. doi: 10.3390/ijms222212506. Int J Mol Sci. 2021. PMID: 34830388 Free PMC article. Review.
-
Gut microbiota in the pathogenesis of inflammatory bowel disease.Clin J Gastroenterol. 2018 Feb;11(1):1-10. doi: 10.1007/s12328-017-0813-5. Epub 2017 Dec 29. Clin J Gastroenterol. 2018. PMID: 29285689 Review.
Cited by
-
Personalizing Nutrition Strategies: Bridging Research and Public Health.J Pers Med. 2024 Mar 13;14(3):305. doi: 10.3390/jpm14030305. J Pers Med. 2024. PMID: 38541047 Free PMC article. Review.
-
Recent updates on correlation between reactive oxygen species and synbiotics for effective management of ulcerative colitis.Front Nutr. 2023 Jul 20;10:1126579. doi: 10.3389/fnut.2023.1126579. eCollection 2023. Front Nutr. 2023. PMID: 37545572 Free PMC article. Review.
-
Intestinal effect of the probiotic Escherichia coli strain Nissle 1917 and its OMV.J Diabetes Metab Disord. 2020 May 1;19(1):597-604. doi: 10.1007/s40200-020-00511-6. eCollection 2020 Jun. J Diabetes Metab Disord. 2020. PMID: 32550212 Free PMC article. Review.
-
Fecal microbiota profiles in treatment-naïve pediatric inflammatory bowel disease - associations with disease phenotype, treatment, and outcome.Clin Exp Gastroenterol. 2019 Jan 31;12:37-49. doi: 10.2147/CEG.S186235. eCollection 2019. Clin Exp Gastroenterol. 2019. PMID: 30774408 Free PMC article.
-
Alterations in the mucosa-associated fungal microbiota in patients with ulcerative colitis.Oncotarget. 2017 Nov 20;8(64):107577-107588. doi: 10.18632/oncotarget.22534. eCollection 2017 Dec 8. Oncotarget. 2017. PMID: 29296188 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources